Literature DB >> 8665493

N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.

N Sadrieh1, C D Davis, E G Snyderwine.   

Abstract

The heterocyclic amines (HCAs) found in cooked meat are procarcinogens that are metabolically activated by N-hydroxylation followed by O-acetylation by the N-acetyltransferases NAT1 and NAT2. Despite the importance of metabolic activation in HCA carcinogenicity and the finding that several HCAs are rodent mammary gland carcinogens, nothing was known about O-acetylation activity in the human mammary gland. The current study examines the expression and catalytic activity of NAT toward the N-hydroxy-HCAs 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-hydroxy-PhIP) and 2-hydroxy-amino-3-methylimidazo[4,5-f]quinoline (N-hydroxy-IQ) in the human mammary gland. Mammary gland cytosol from 10 women and lysates from a primary culture of human mammary epithelial cells metabolically activated 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline by NAT-mediated 0-acetyltransferase, as measured by the acetyl CoA-enhanced binding of the N-hydroxylamines to calf thymus DNA in vitro. N-acetylation of p-aminosalicylic, an activity specific to NAT1, but not N-acetylation of sulfamethazine, an activity specific to NAT2, was detected in the mammary gland cytosols and human mammary epithelial cell lysates. Immunohistochemical analysis of human mammary gland sections showed positive staining for NAT1 protein in the epithelial cells lining the mammary gland ducts. Reverse transcription-PCR analysis showed that mRNA transcripts for both NAT1 and NAT2 were present in human mammary gland; however, no NAT2 catalytic activity was detectable. Our data demonstrate for the first time that the human mammary gland is catalytically active toward the metabolic activation of HCA food mutagens, and that this activity is most likely contributed by NAT1 expressed in the ductular epithelial cells of the mammary gland.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665493

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

2.  Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.

Authors:  Joseph R Kurian; Nathaniel A Chin; Brett J Longlais; Kristie L Hayes; Lauren A Trepanier
Journal:  Chem Res Toxicol       Date:  2006-10       Impact factor: 3.739

3.  4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.

Authors:  Felicia A Jefferson; Gong H Xiao; David W Hein
Journal:  Toxicol Sci       Date:  2008-10-08       Impact factor: 4.849

4.  High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5α-androstane-3β,17β-Diol, or Dihydrotestosterone in Breast Cancer Cells.

Authors:  Xiaoyan Zhang; Samantha M Carlisle; Mark A Doll; Robert C G Martin; J Christopher States; Carolyn M Klinge; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

5.  2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.

Authors:  T D Bradshaw; S Wrigley; D F Shi; R J Schultz; K D Paull; M F Stevens
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

6.  Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445).

Authors:  T D Bradshaw; M S Chua; S Orr; C S Matthews; M F Stevens
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

7.  Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma.

Authors:  A Khedhaier; S Remadi; M Corbex; S B Ahmed; N Bouaouina; S Mestiri; R Azaiez; A N Helal; L Chouchane
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

8.  Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.

Authors:  Samantha M Carlisle; David W Hein
Journal:  Int J Oncol       Date:  2018-06-11       Impact factor: 5.650

9.  Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia.

Authors:  Roza Pavlovna Tiis; Ludmila Pavlovna Osipova; Daria Veniaminovna Lichman; Elena Nikolaevna Voronina; Maxim Leonidovich Filipenko
Journal:  BMC Genet       Date:  2020-10-22       Impact factor: 2.797

10.  Validation of the 3D reconstructed human skin Comet assay, an animal-free alternative for following-up positive results from standard in vitro genotoxicity assays.

Authors:  Stefan Pfuhler; Ralph Pirow; Thomas R Downs; Andrea Haase; Nicola Hewitt; Andreas Luch; Marion Merkel; Claudia Petrick; André Said; Monika Schäfer-Korting; Kerstin Reisinger
Journal:  Mutagenesis       Date:  2021-04-28       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.